Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. (2021)
Attributed to:
Optimising therapeutic strategy in psoriasis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2020.10.007
PubMed Identifier: 33075408
Publication URI: http://europepmc.org/abstract/MED/33075408
Type: Journal Article/Review
Volume: 147
Parent Publication: The Journal of allergy and clinical immunology
Issue: 1
ISSN: 0091-6749